Serenzin en es it fr

Serenzin Brand names, Serenzin Analogs

Serenzin Brand Names Mixture

  • No information avaliable

Serenzin Chemical_Formula

C16H13ClN2O

Serenzin RX_link

http://www.rxlist.com/cgi/generic/diazepam.htm

Serenzin fda sheet

Serenzin msds (material safety sheet)

Serenzin MSDS

Serenzin Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Serenzin Molecular Weight

284.74 g/mol

Serenzin Melting Point

125-126oC

Serenzin H2O Solubility

Slightly soluble (50 mg/L)

Serenzin State

solid

Serenzin LogP

2.988

Serenzin Dosage Forms

Tablets; Injectable solution

Serenzin Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Serenzin Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Serenzin Absorption

Essentially complete, with a bioavailability of 93%.

Serenzin side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Serenzin Patient Information

Serenzin Organisms Affected

Humans and other mammals